
|Articles|March 9, 2022
Sanofi Recognized by S&P
Advertisement
Sanofi was recognized as one of the most sustainability-committed companies in an ESG Evaluation (Environment, Social, Governance) performed by Standard & Poor’s Global Ratings (S&P).
The ESG Evaluation awarded Sanofi a score of 86 out of 100 points, one of the highest scores across all sectors globally. Sanofi’s ESG profile was awarded 80 points for its solid fundamentals, completed with an additional strong preparedness opinion of 6 points awarded for its ‘excellent awareness of risks and opportunities’ and its capacity to ‘anticipate and adapt to a variety of long-term plausible disruptions.’
Read more about the recognition
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising, Alleging Misleading Dosing Comparisons
2
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
3
Developing Better Drugs, Not Just More Drugs: Q&A with David Hung
4
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
5




